Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
ASCO June 2-6, 2017 in Chicago. Might only be attending. No abstract/title found in program search.
BIO International June 19-22, 2017 in San Diego. Presenting.